메뉴 건너뛰기




Volumn 58, Issue 3, 2009, Pages 373-378

Relationship between changes in insulin sensitivity and associated cardiovascular disease risk factors in thiazolidinedione-treated, insulin-resistant, nondiabetic individuals: pioglitazone versus rosiglitazone

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; PIOGLITAZONE; ROSIGLITAZONE;

EID: 59649088286     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.10.011     Document Type: Article
Times cited : (17)

References (32)
  • 1
    • 0036551421 scopus 로고    scopus 로고
    • A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone
    • Khan M.A., St Peter J.V., and Xue J.L. A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone. Diabetes Care 25 (2002) 708-711
    • (2002) Diabetes Care , vol.25 , pp. 708-711
    • Khan, M.A.1    St Peter, J.V.2    Xue, J.L.3
  • 2
    • 21544466158 scopus 로고    scopus 로고
    • A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia
    • Goldberg R.B., Kendall D.M., Deeg M.A., et al. A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. Diabetes Care 28 (2005) 1547-1554
    • (2005) Diabetes Care , vol.28 , pp. 1547-1554
    • Goldberg, R.B.1    Kendall, D.M.2    Deeg, M.A.3
  • 3
    • 34447643245 scopus 로고    scopus 로고
    • Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study
    • Chappuis B., Braun M., Stettler C., et al. Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study. Diabetes Metab Res Rev 23 (2007) 392-399
    • (2007) Diabetes Metab Res Rev , vol.23 , pp. 392-399
    • Chappuis, B.1    Braun, M.2    Stettler, C.3
  • 4
    • 35148837113 scopus 로고    scopus 로고
    • Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia
    • Deeg M.A., Buse J.B., Goldberg R.B., et al. Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia. Diabetes Care 30 (2007) 2458-2464
    • (2007) Diabetes Care , vol.30 , pp. 2458-2464
    • Deeg, M.A.1    Buse, J.B.2    Goldberg, R.B.3
  • 5
    • 0024160877 scopus 로고
    • Banting lecture 1988. Role of insulin resistance in human disease
    • Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
    • (1988) Diabetes , vol.37 , pp. 1595-1607
    • Reaven, G.M.1
  • 6
    • 0028947949 scopus 로고
    • The fourth musketeer-from Alexandre Dumas to Claude Bernard
    • Reaven G.M. The fourth musketeer-from Alexandre Dumas to Claude Bernard. Diabetologia 38 (1995) 3-13
    • (1995) Diabetologia , vol.38 , pp. 3-13
    • Reaven, G.M.1
  • 7
    • 0028023850 scopus 로고
    • Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test
    • Pei D., Jones C.N., Bhargava R., Chen Y.D., and Reaven G.M. Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 37 (1994) 843-845
    • (1994) Diabetologia , vol.37 , pp. 843-845
    • Pei, D.1    Jones, C.N.2    Bhargava, R.3    Chen, Y.D.4    Reaven, G.M.5
  • 8
    • 0014898491 scopus 로고
    • Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes
    • Shen S.W., Reaven G.M., and Farquhar J.W. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 49 (1970) 2151-2160
    • (1970) J Clin Invest , vol.49 , pp. 2151-2160
    • Shen, S.W.1    Reaven, G.M.2    Farquhar, J.W.3
  • 9
    • 0019450068 scopus 로고
    • Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp
    • Greenfield M.S., Doberne L., Kraemer F., Tobey T., and Reaven G. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 30 (1981) 387-392
    • (1981) Diabetes , vol.30 , pp. 387-392
    • Greenfield, M.S.1    Doberne, L.2    Kraemer, F.3    Tobey, T.4    Reaven, G.5
  • 10
    • 0033984997 scopus 로고    scopus 로고
    • Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers
    • Yeni-Komshian H., Carantoni M., Abbasi F., and Reaven G.M. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 23 (2000) 171-175
    • (2000) Diabetes Care , vol.23 , pp. 171-175
    • Yeni-Komshian, H.1    Carantoni, M.2    Abbasi, F.3    Reaven, G.M.4
  • 11
    • 0031726145 scopus 로고    scopus 로고
    • Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease
    • Yip J., Facchini F.S., and Reaven G.M. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 83 (1998) 2773-2776
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 2773-2776
    • Yip, J.1    Facchini, F.S.2    Reaven, G.M.3
  • 13
    • 0034926963 scopus 로고    scopus 로고
    • Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity
    • McLaughlin T., Abbasi F., Lamendola C., Kim H.S., and Reaven G.M. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity. Metabolism 50 (2001) 819-824
    • (2001) Metabolism , vol.50 , pp. 819-824
    • McLaughlin, T.1    Abbasi, F.2    Lamendola, C.3    Kim, H.S.4    Reaven, G.M.5
  • 14
    • 0015348189 scopus 로고
    • Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
    • Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
    • (1972) Clin Chem , vol.18 , pp. 499-502
    • Friedewald, W.T.1    Levy, R.I.2    Fredrickson, D.S.3
  • 15
    • 0042855872 scopus 로고    scopus 로고
    • International physical activity questionnaire: 12-country reliability and validity
    • Craig C.L., Marshall A.L., Sjostrom M., et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35 (2003) 1381-1395
    • (2003) Med Sci Sports Exerc , vol.35 , pp. 1381-1395
    • Craig, C.L.1    Marshall, A.L.2    Sjostrom, M.3
  • 16
    • 0016292507 scopus 로고
    • Reappraisal of the role of insulin in hypertriglyceridemia
    • Olefsky J.M., Farquhar J.W., and Reaven G.M. Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 57 (1974) 551-560
    • (1974) Am J Med , vol.57 , pp. 551-560
    • Olefsky, J.M.1    Farquhar, J.W.2    Reaven, G.M.3
  • 17
    • 0018880112 scopus 로고
    • Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia
    • Greenfield M., Kolterman O., Olefsky J., and Reaven G.M. Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia. Diabetologia 18 (1980) 441-446
    • (1980) Diabetologia , vol.18 , pp. 441-446
    • Greenfield, M.1    Kolterman, O.2    Olefsky, J.3    Reaven, G.M.4
  • 18
    • 0019739196 scopus 로고
    • Diabetic hypertriglyceridemia: evidence for three clinical syndromes
    • Reaven G.M., and Greenfield M.S. Diabetic hypertriglyceridemia: evidence for three clinical syndromes. Diabetes 30 (1981) 66-75
    • (1981) Diabetes , vol.30 , pp. 66-75
    • Reaven, G.M.1    Greenfield, M.S.2
  • 20
    • 0013963288 scopus 로고
    • Glucose, insulin, and triglyceride responses to high and low carbohydrate diets in man
    • Farquhar J.W., Frank A., Gross R.C., and Reaven G.M. Glucose, insulin, and triglyceride responses to high and low carbohydrate diets in man. J Clin Invest 45 (1966) 1648-1656
    • (1966) J Clin Invest , vol.45 , pp. 1648-1656
    • Farquhar, J.W.1    Frank, A.2    Gross, R.C.3    Reaven, G.M.4
  • 21
    • 0033677952 scopus 로고    scopus 로고
    • Carbohydrate-induced hypertriglyceridemia: an insight into the link between plasma insulin and triglyceride concentrations
    • McLaughlin T., Abbasi F., Lamendola C., Yeni-Komshian H., and Reaven G. Carbohydrate-induced hypertriglyceridemia: an insight into the link between plasma insulin and triglyceride concentrations. J Clin Endocrinol Metab 85 (2000) 3085-3088
    • (2000) J Clin Endocrinol Metab , vol.85 , pp. 3085-3088
    • McLaughlin, T.1    Abbasi, F.2    Lamendola, C.3    Yeni-Komshian, H.4    Reaven, G.5
  • 22
    • 0015953288 scopus 로고
    • Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects
    • Olefsky J., Reaven G.M., and Farquhar J.W. Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. J Clin Invest 53 (1974) 64-76
    • (1974) J Clin Invest , vol.53 , pp. 64-76
    • Olefsky, J.1    Reaven, G.M.2    Farquhar, J.W.3
  • 23
    • 0034926959 scopus 로고    scopus 로고
    • Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women
    • McLaughlin T., Abbasi F., Kim H.S., Lamendola C., Schaaf P., and Reaven G. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. Metabolism 50 (2001) 795-800
    • (2001) Metabolism , vol.50 , pp. 795-800
    • McLaughlin, T.1    Abbasi, F.2    Kim, H.S.3    Lamendola, C.4    Schaaf, P.5    Reaven, G.6
  • 24
    • 20944439286 scopus 로고    scopus 로고
    • Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus
    • Nagashima K., Lopez C., Donovan D., et al. Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus. J Clin Invest 115 (2005) 1323-1332
    • (2005) J Clin Invest , vol.115 , pp. 1323-1332
    • Nagashima, K.1    Lopez, C.2    Donovan, D.3
  • 25
    • 43249083632 scopus 로고    scopus 로고
    • Dissociation between the insulin-sensitizing effect of rosiglitazone and its effect on hepatic and intestinal lipoprotein production
    • Duez H., Lamarche B., Uffelman K.D., et al. Dissociation between the insulin-sensitizing effect of rosiglitazone and its effect on hepatic and intestinal lipoprotein production. J Clin Endocrinol Metab 93 (2008) 1722-1729
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 1722-1729
    • Duez, H.1    Lamarche, B.2    Uffelman, K.D.3
  • 26
    • 33244496643 scopus 로고    scopus 로고
    • The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients
    • Al Majali K., Cooper M.B., Staels B., Luc G., Taskinen M.R., and Betteridge D.J. The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients. Diabetologia 49 (2006) 527-537
    • (2006) Diabetologia , vol.49 , pp. 527-537
    • Al Majali, K.1    Cooper, M.B.2    Staels, B.3    Luc, G.4    Taskinen, M.R.5    Betteridge, D.J.6
  • 27
    • 0042669791 scopus 로고    scopus 로고
    • Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT)
    • Robins S.J., Rubins H.B., Faas F.H., et al. Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care 26 (2003) 1513-1517
    • (2003) Diabetes Care , vol.26 , pp. 1513-1517
    • Robins, S.J.1    Rubins, H.B.2    Faas, F.H.3
  • 28
    • 0018649439 scopus 로고
    • Atherogenesis: a postprandial phenomenon
    • Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation 60 (1979) 473-485
    • (1979) Circulation , vol.60 , pp. 473-485
    • Zilversmit, D.B.1
  • 29
    • 34447511196 scopus 로고    scopus 로고
    • Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
    • Nordestgaard B.G., Benn M., Schnohr P., and Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. Jama 298 (2007) 299-308
    • (2007) Jama , vol.298 , pp. 299-308
    • Nordestgaard, B.G.1    Benn, M.2    Schnohr, P.3    Tybjaerg-Hansen, A.4
  • 30
    • 34447520136 scopus 로고    scopus 로고
    • Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
    • Bansal S., Buring J.E., Rifai N., Mora S., Sacks F.M., and Ridker P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. Jama 298 (2007) 309-316
    • (2007) Jama , vol.298 , pp. 309-316
    • Bansal, S.1    Buring, J.E.2    Rifai, N.3    Mora, S.4    Sacks, F.M.5    Ridker, P.M.6
  • 31
    • 26244453309 scopus 로고    scopus 로고
    • Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
    • Dormandy J.A., Charbonnel B., Eckland D.J., et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366 (2005) 1279-1289
    • (2005) Lancet , vol.366 , pp. 1279-1289
    • Dormandy, J.A.1    Charbonnel, B.2    Eckland, D.J.3
  • 32
    • 34250212715 scopus 로고    scopus 로고
    • Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
    • Nissen S.E., and Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356 (2007) 2457-2471
    • (2007) N Engl J Med , vol.356 , pp. 2457-2471
    • Nissen, S.E.1    Wolski, K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.